once vaccines are approved for children, “we need to think about this logically in the same way we’ve approached the adult program,” sadarangani said, meaning, who should get priority?
“think about the current vaccines we use in children,” he said. “there are very few that we vaccinate across the entire childhood spectrum.” most are targeted at specific age groups, some particularly at infants, where the most severe disease or transmission occurs, others adolescents.
pfizer inc and biontech said this week, citing as yet unpublished data, that their covid-19 vaccine was 100 per cent effective and produced “robust” antibody responses in 12 to 15-year-olds, based on early results from a phase 3 trial involving 2,260 teens (the adult trials involved 30,000). the company has also begun testing its vaccine on children as young as six months. moderna, johnson & johnson, novavax and oxford-astrazeneca have already begun, or plan to, test their vaccines in young children.
age reigns supreme as the greatest risk factor for severe outcomes from covid — hospitalizations and deaths. so far, six deaths have been reported in the youngest age group (0 to 19).
the same age group accounts for about 1.6 per cent of hospitalizations in canada, according to data compiled by the canadian paediatric surveillance program. almost half of those are incidental: a child arrives in emergency with a bone fracture, and a routine screening test happens to pick up covid.